Login to Your Account

Industry told to get on board with efforts to lower U.S. drug prices

By Mari Serebrov
Regulatory Editor

Thursday, May 17, 2018

Like it or not, "we are going to bring negotiation to [Medicare] Part B drugs, and we are going to give Part D plans more bargaining power," U.S. Health and Human Services (HHS) Secretary Alex Azar vowed Wednesday, taking aim at industry pushback on the Trump administration's plan to bring down prescription drug prices.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription